Change in the responsibility areas of Orion Group Executive

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Change in the responsibility areas of Orion Group Executive Management Board as of 1 January 2014

ORION CORPORATION        STOCK EXCHANGE RELEASE 19 NOVEMBER 2013 at 12:10 p.m. EET The following change has been made in the responsibility areas of Orion Group Executive Management Board as of 1 January 2014: Mr. Markku Huhta-Koivisto, Senior Vice President responsible for Specialty Products and Fermion business divisions and Dr. Liisa Hurme, Senior Vice President responsible for Proprietary Products business division will exchange their responsibility areas. Thus, as of 1 January 2014, Markku Huhta-Koivisto, Senior Vice President, will be responsible for Proprietary Products business division, and Liisa Hurme, Senior Vice President, will be responsible for Specialty Products and Fermion business divisions. They both continue to be members of the Orion Group Executive Management Board as previously. Timo Lappalainen, President and CEO, says: "I am pleased that we can develop the Executive Management Board's operations in a flexible way by this exchange of responsibility areas. I believe that the change will give, not only a good possibility for Liisa and Markku for job rotation, but also that it will bring positive effects for the whole Executive Management Board and the company." Orion Corporation Timo Lappalainen     Olli Huotari President and CEO SVP, Corporate Functions Contact person: Timo Lappalainen, President and CEO, phone: +358 50 966 3692 Publisher: Orion Corporation Communications Orionintie 1A, FI-02200 Espoo, Finland Homepage: www.orion.fi Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R&D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler® pulmonary drugs. Orion's net sales in 2012 amounted to EUR 980 million and the company had about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki. [HUG#1744144]

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 35

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 19

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 47

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 31

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 26

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 37

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 29

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

ConocoPhillips Prepares for Third Quarter Earnings Report

Updated Category News Views 132

ConocoPhillips Earnings Preview ConocoPhillips (NYSE: COP) is set to unveil its earnings results for the third quarter, drawing significant attention from investors and analysts alike. This report is expected to be released before the opening bell on the designated Thursday. Analysts project that ConocoPhillips will report earnings of $1.41 per share, a decrease from...

Continue Reading
Tesla's FSD Ambitions Shine Amid Market Uncertainty

Updated Category News Views 138

Tesla's Ambitious Goals for Full Self-Driving Technology Tesla, Inc. TSLA is pursuing an ambitious plan to introduce its groundbreaking full self-driving (FSD) technology to markets around the world, with a particular focus on regions in Asia and Europe. What to Anticipate from Tesla's FSD Launch Industry expert Greg Migliore, editor-in-chief of Real Auto Blog, bel

Continue Reading
Centners Pursue $885M Defamation Case Against Local Newspaper

Updated Category News Views 230

Centners File Major Defamation Lawsuit Against a Newspaper Philanthropists and entrepreneurs David and Leila Centner have taken a significant step by initiating a defamation lawsuit against a prominent newspaper and several journalists. They are asserting that the newspaper has intentionally misrepresented public records regarding their generous donation intentions aimed...

Continue Reading
NACCO Industries Reports Solid Performance Amid Challenges

Updated Category News Views 140

NACCO Industries Announces Second Quarter Results NACCO Industries, Inc. (NYSE: NC) has revealed its consolidated results for the three and six months ending in June 2025. The company faced some short-term operational challenges, impacting their ability to meet expected growth targets. Despite this setback, NACCO's versatile sectors remain primed for recovery and...

Continue Reading
Unlocking Income: Earning $500 Monthly from Jefferies Stock

Updated Category News Views 100

Understanding Jefferies Financial Group Inc. Jefferies Financial Group Inc. (NYSE: JEF) is a key player in the financial services sector, known for its robust investment banking operations and diverse financial solutions. With the company's upcoming earnings report for the fourth quarter, there’s excitement surrounding its performance and future potential. Although the...

Continue Reading